Methods and compositions for modulation of blood-neural barrier
Details for Australian Patent Application No. 2007240429 (hide)
International Classifications
Event Publications
20 November 2008 PCT application entered the National Phase
PCT publication WO2007/124308 Priority application(s): WO2007/124308
19 March 2009 Alteration of Name
The name of the applicant has been altered to Ludwig Institute for Cancer Research Ltd
13 September 2012 Assignment before Grant
Ludwig Institute for Cancer Research Ltd The application has been assigned to Ludwig Institute for Cancer Research Ltd; University of Maryland, Baltimore; The Regents of the University of Michigan
20 September 2012 Corrigenda
Assignments Before Grant, Section 113 - 2007 Under the name Ludwig Institute for Cancer Research Ltd; The Regents of the University of Michigan; University of Maryland, Baltimore, Application No. 2007240429, Under INID (71), corrected the applicant name(s) to Ludwig Institute for Cancer Research Ltd; The Regents of the University of Michigan; University of Maryland
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2007240430-Methods for detecting mutations in JAK2 nucleic acid
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser